From: Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer
Measure
Rate
Point estimate
95% lower limit (1-sided)
95% upper limit (1-sided)
Overall Diagnostic Agreement
124/130
95.38
91.32
100
Positive Diagnostic Agreement
55/59
93.22
85.73
Negative Diagnostic Agreement
69/71
97.18
91.84